ERJ staff report (DS)
Abingdon, UK - Green Biologics Limited (GBL), a UK-based industrial biotechnology company announces the merger between GBL and butylfuel Inc., a US-based renewable chemicals and biofuels company.
The new company will operate under the Green Biologics name and continue to be head-quartered in Abingdon, UK with a strong operational presence and commercial focus in the US contributed by butylfuelâ„¢ Inc., which will become Green Biologics, Inc. The effective date for the all equity merger is January 1, 2012.
"This merger creates a truly global leader in biobutanol and represents a transformational deal for both companies," says Sean Sutcliffe, CEO of the combined GBL group. The company is not immediately focussed on the elastomer or polymer business.
This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.
Press release from Green Biologics Limited